Industry Relationships |
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of March 12, 2013, Dr. Healey reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Seibel NL, Krailo M, Chen Z, Healey J, Breitfeld PP, Drachtman R, Greffe B, Nachman J, Nadel H, Sato JK, Meyers PA, Reaman GH. Upfront Window Trial of Topotecan in Previously Untreated Children and Adolescents with Poor Prognosis in Metastatic Osteosarcoma: Children's Cancer Group (CCG) 7943. Cancer. March, 2007 2;109(8):1646-1653.
Chen CM, Disa JJ, Lee HY, Mehrara BJ, Hu QY, Nathan S, Boland P, Healey J, Cordeiro PG. Reconstruction of Extremity Long Bone Defects After Sarcoma Resection with Vascularized Fibula Flaps: A 10-year Review. Plast Reconstr Surg. 2007 Mar;119(3):915-24; discussion 925-6.
Yang R, Kolb EA, Qin J, Chou A, Sowers R, Hoang B, Healey J, Huvos AG, Meyers PA, Gorlick R. The Folate Receptor {alpha} Is Frequently Overexpressed in Osteo Sarcoma Samples and Plays a Role in the Uptake of the Physiologic Substrate 5-Methyltetrahydrofolate. Clin Cancer Res. 2007 May 1;13(9):2557-2567.
Biermann JS, Adkins D, Benjamin R, Brigman B, Chow W, Conrad EU 3rd, Frassica D, Frassica FJ, George S, Healey J, Heck R Jr., Letson GD, Mayerson J, McGarry SV, O'Donnell RJ, Patt J, Randall RL, Santana V, Satcher RL, Schmidt G, Siegel HJ, Wong MK, Yasko AW. Bone Cancer. J Natl Compr Canc Netw. 2007 Apr; 5(4):420-37.
Schwab JH, Boland P, Guo T, Brennan MF, Singer S, Healey J, Antonescu CR. Skeletal Metastases in Myxoid Liposarcoma: An Unusual Pattern of Distant Spread. Ann Surg Oncol. 2007 Apr;14(4):1507-14.
Schwab, JH and Healey J. FDG-PET Lacks Sufficient Sensitivity to Detect Myxoid Liposarcoma Spinal Metastases Detected by MRI. Sarcoma 2007: 2007 Article ID 36785. 2007.
DiResta GR, Aiken SW, Brown HK, Bergman PJ, Hohenhaus A, Ehrhart EJ, Baer K, Healey J. Use of An Artificial Lymphatic System During Carboplatin Infusion to Improve Canine Osteosarcoma Blood Flow and Clinical Response. Ann Surg Oncol. 2007 Aug;14(8):2411-421.
Diresta GR, Aiken SW, Brown HK, Bergman PJ, Hohenhaus A, Healey J. Influence of Carboplatin Infusion on Osteosarcoma Blood Flow. Cancer Chemother Pharmacol. 2007 Oct 12; [Epub ahead of print].
Arkader A, Huvos AG, Healey J. Multifocal Synchronous Low-Grade Intramedullary and Juxtacortical Osteogenic Sarcoma. Clin Orthop Relat Res. 2007 Dec; 465:265-270.
Schwab JH, Healey J, Athanasian EA. Wide En Bloc Extra-Articular Excision of the Elbow for Sarcoma with Complex Reconstruction. J Bone Joint Surg Br. 2008 Jan; 90(1):78-83.
For more publications, please see the PubMed listing.
© Hospital for Special Surgery. 535 East 70th Street, New York, NY 10021